Edesa Biotech, Inc.
EDSA
$1.96
-$0.075-3.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.42% | 20.85% | 26.32% | 26.82% | 45.40% |
| Total Depreciation and Amortization | -25.62% | -8.54% | 1.36% | 12.79% | 93.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -62.81% | -61.77% | -58.07% | -20.20% | -42.49% |
| Change in Net Operating Assets | -54.69% | 200.72% | 85.33% | 115.05% | 48.60% |
| Cash from Operations | 9.71% | 20.01% | 26.31% | 50.07% | 47.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | 300.08% | -56.68% | -85.74% | -73.81% | -49.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -187.44% | -8.43% | 62.23% | 31.14% | -70.33% |
| Cash from Financing | 912.45% | 6.02% | -87.74% | -76.55% | -54.54% |
| Foreign Exchange rate Adjustments | -3,400.00% | -340.39% | -133.68% | -319.42% | 96.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 337.54% | 32.43% | -150.01% | 30.47% | 44.49% |